ES2139043T3 - Compuestos de azaciclohexapeptidos. - Google Patents

Compuestos de azaciclohexapeptidos.

Info

Publication number
ES2139043T3
ES2139043T3 ES94200604T ES94200604T ES2139043T3 ES 2139043 T3 ES2139043 T3 ES 2139043T3 ES 94200604 T ES94200604 T ES 94200604T ES 94200604 T ES94200604 T ES 94200604T ES 2139043 T3 ES2139043 T3 ES 2139043T3
Authority
ES
Spain
Prior art keywords
compounds
azaciclohexapeptide
ceretain
azo
found
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94200604T
Other languages
English (en)
Inventor
James M Balkovec
Frances Aileen Bouffard
Regina M Black
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21867140&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2139043(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of ES2139043T3 publication Critical patent/ES2139043T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

COMPUESTOS DE CERETAIN AZO CICLOHEXAPEPTIDO SE HAN ENCONTRADO PARA TENER PROPIEDADES ANTIBIOTICAS SUPERIORES. NUEVOS PROCESOS PARA SU PREPARACION TAMBIEN SE DESCRIBEN.
ES94200604T 1993-03-16 1994-03-09 Compuestos de azaciclohexapeptidos. Expired - Lifetime ES2139043T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/032,847 US5378804A (en) 1993-03-16 1993-03-16 Aza cyclohexapeptide compounds

Publications (1)

Publication Number Publication Date
ES2139043T3 true ES2139043T3 (es) 2000-02-01

Family

ID=21867140

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94200604T Expired - Lifetime ES2139043T3 (es) 1993-03-16 1994-03-09 Compuestos de azaciclohexapeptidos.

Country Status (32)

Country Link
US (3) US5378804A (es)
EP (1) EP0620232B1 (es)
JP (1) JP2568474B2 (es)
KR (1) KR100329693B1 (es)
CN (1) CN1098274C (es)
AT (1) ATE186736T1 (es)
AU (1) AU668804B2 (es)
BG (1) BG63047B1 (es)
BR (2) BR9406009A (es)
CA (1) CA2118757C (es)
CZ (1) CZ286235B6 (es)
DE (2) DE10299013I2 (es)
DK (1) DK0620232T3 (es)
ES (1) ES2139043T3 (es)
FI (1) FI109542B (es)
GR (1) GR3031872T3 (es)
HR (1) HRP940161B1 (es)
HU (2) HU217614B (es)
IL (1) IL108892A (es)
LU (1) LU90875I2 (es)
LV (1) LV12574B (es)
NL (1) NL300076I2 (es)
NO (2) NO318372B1 (es)
NZ (1) NZ263360A (es)
PL (1) PL179261B1 (es)
RO (1) RO113246B1 (es)
RU (1) RU2122548C1 (es)
SI (1) SI9420013B (es)
SK (1) SK282527B6 (es)
UA (1) UA59329C2 (es)
WO (1) WO1994021677A1 (es)
ZA (1) ZA941807B (es)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874403A (en) * 1992-10-15 1999-02-23 Merck & Co., Inc. Amino acid conjugates of cyclohexapeptidyl amines
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
US5948753A (en) * 1993-05-04 1999-09-07 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
ATE186737T1 (de) * 1994-08-23 1999-12-15 Merck & Co Inc Ein verbessertes verfahren für die herstellung von seitenketten-derivaten von cyclohexapeptidyl- lipopeptiden
US5514651A (en) * 1994-09-16 1996-05-07 Merck & Co., Inc. Aza cyclohexapeptide compounds
EP0781141B1 (en) * 1994-09-16 2002-09-04 Merck & Co. Inc. Aza cyclohexapeptide compounds
US5516757A (en) * 1994-09-16 1996-05-14 Merck & Co., Inc. Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use
US5516756A (en) * 1994-10-31 1996-05-14 Merck & Co., Inc. Aza cyclohexapeptide compounds
EP0805685B1 (en) * 1995-01-26 2001-09-26 Merck & Co., Inc. Novel antifungal cyclohexapeptides
US5552521A (en) * 1995-02-10 1996-09-03 Merck & Co., Inc. Process for preparing certain aza cyclohexapeptides
AU707664B2 (en) * 1995-11-09 1999-07-15 Merck & Co., Inc. Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use
US5952300A (en) * 1996-04-19 1999-09-14 Merck & Co., Inc. Antifungal compositions
PE63998A1 (es) * 1996-04-19 1998-10-30 Merck & Co Inc Composiciones anti-fungosas
HRP970318B1 (en) * 1996-06-14 2002-06-30 Merck & Co Inc A process for preparing certain aza cyclohexapeptides
DE69724626T2 (de) * 1996-09-12 2004-07-29 Merck & Co., Inc. Fungizide kombinationstherapie
USRE38984E1 (en) * 1996-09-12 2006-02-14 Merck & Co., Inc. Antifungal combination therapy
US5854212A (en) * 1996-10-23 1998-12-29 Merck & Co., Inc. Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use
US5936062A (en) * 1997-06-12 1999-08-10 Merck & Co., Inc. Process for preparing certain aza cyclohexapeptides
US7166572B1 (en) * 1999-07-27 2007-01-23 Aventis Pharma Deutschland Gmbh Cyclohexapeptide compounds, processes for their production and their use as a pharmaceutical
AR035808A1 (es) * 2001-04-12 2004-07-14 Merck & Co Inc Proceso de deshidratacion capaz de minimizar la epimerizacion de un grupo hidroxilo por ciertas equinocandinas
ATE430160T1 (de) * 2001-08-06 2009-05-15 Cubist Pharm Inc Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
EP2316469A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
US7214768B2 (en) * 2002-04-08 2007-05-08 Merck & Co., Inc. Echinocandin process
JP4664912B2 (ja) * 2003-07-22 2011-04-06 セラヴァンス， インコーポレーテッド グリコペプチド抗菌剤と組み合わせたエキノカンジン抗真菌剤の使用
CN1950396A (zh) * 2004-02-24 2007-04-18 联邦科学技术研究组织 抗真菌肽
EP1785432A1 (en) 2005-11-15 2007-05-16 Sandoz AG Process and intermediates for the synthesis of caspofungin.
WO2008012310A1 (en) * 2006-07-26 2008-01-31 Sandoz Ag Caspofungin formulations
TW200826957A (en) * 2006-10-16 2008-07-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Purification processes for echinocandin-type compounds
US20100137197A1 (en) 2007-06-26 2010-06-03 Sachin Mittal Lyophilized anti-fungal composition
US20090075870A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched caspofungin
US20090291996A1 (en) * 2008-05-21 2009-11-26 Ferenc Korodi Caspofungin free of caspofungin Co
US8048853B2 (en) 2008-06-13 2011-11-01 Xellia Pharmaceuticals Aps Process for preparing pharmaceutical compound and intermediates thereof
KR20110011704A (ko) * 2008-06-25 2011-02-08 테바 기오기스제르갸르 자르트쾨렌 뮈쾨되 레스즈베니타르사사그 카스포펀진 불순물 ａ를 함유하지 않는 카스포펀진
US20100256074A1 (en) * 2008-06-25 2010-10-07 Chaim Eidelman Processes for preparing high purity aza cyclohexapeptides
WO2010064219A1 (en) 2008-12-04 2010-06-10 Ranbaxy Laboratories Limited Process for the preparation of a novel intermediate for caspofungin
TW201024322A (en) * 2008-12-31 2010-07-01 Chunghwa Chemical Synthesis & Biotech Co Ltd Preparation method for nitrogen containing heterocyclic hexapeptide with high conversion rate
WO2010108637A1 (en) 2009-03-27 2010-09-30 Axellia Pharmaceuticals Aps Crystalline compound
CN101602795B (zh) * 2009-07-20 2011-12-21 中国人民解放军第二军医大学 环六脂肽胺类抗真菌化合物及其盐类和制备方法
EP2463293A4 (en) * 2009-08-06 2013-06-05 Shanghai Techwell Biopharm Co AZACYCLOHEXAPEPTIDE BZW. ITS PHARMACEUTICAL ACCEPTABLE SALT, MANUFACTURING PROCESS AND USE
US8751760B2 (en) * 2009-10-01 2014-06-10 Dell Products L.P. Systems and methods for power state transitioning in an information handling system
CN101792486A (zh) * 2010-04-12 2010-08-04 浙江海正药业股份有限公司 一种合成醋酸卡泊芬净的方法
CN102219832B (zh) * 2010-04-15 2013-08-21 上海天伟生物制药有限公司 一种氮杂环六肽或其盐的纯化方法
CN103118663A (zh) 2010-09-20 2013-05-22 赛利亚医药公司 卡泊芬净组合物
KR101514903B1 (ko) * 2010-09-29 2015-04-23 샹하이 테크웰 바이오파마슈티컬 컴퍼니, 리미티드 사이클릭 리포펩타이드 화합물 또는 그의 염의 정제방법
KR101514904B1 (ko) * 2010-09-30 2015-04-23 샹하이 테크웰 바이오파마슈티컬 컴퍼니, 리미티드 사이클릭 리포펩타이드 화합물 또는 그의 염의 정제방법
CN102367269B (zh) 2010-11-10 2013-11-06 上海天伟生物制药有限公司 一种卡泊芬净类似物及其制备方法和用途
CN102367267B (zh) 2010-11-10 2013-09-04 上海天伟生物制药有限公司 一种卡泊芬净的制备方法
CN102367268B (zh) 2010-11-10 2013-11-06 上海天伟生物制药有限公司 一种卡泊芬净类似物及其用途
KR101331984B1 (ko) 2010-12-09 2013-11-25 종근당바이오 주식회사 카스포펀진 제조방법 및 그의 신규 중간체
WO2012093293A1 (en) * 2011-01-03 2012-07-12 Biocon Limited Process for preparation of caspofungin acetate and intermediates
CN102618606B (zh) * 2011-01-30 2014-09-10 浙江海正药业股份有限公司 一种棘白菌素生物转化方法
HRP20171579T8 (hr) 2011-03-03 2018-12-14 Cidara Therapeutics, Inc. Antigljivična sredstva i njihova upotreba
CN102746384B (zh) 2011-04-22 2016-01-20 上海天伟生物制药有限公司 一种高纯度的卡泊芬净或其盐及其制备方法和用途
RU2592280C2 (ru) 2011-04-28 2016-07-20 Юнитрис Биофарма Ко., Лтд Промежуточное соединение для синтеза каспофунгина и способ его получения
CN104507309B (zh) 2012-03-19 2017-05-03 奇达拉治疗公司 用于棘白菌素类化合物的给药方案
WO2014081443A1 (en) * 2012-11-20 2014-05-30 Fresenius Kabi Usa, Llc Caspofungin acetate formulations
CN112110991A (zh) * 2014-12-24 2020-12-22 上海天伟生物制药有限公司 一种含氮杂环六肽前体的组合物及其制备方法和用途
WO2017034961A1 (en) 2015-08-21 2017-03-02 Trilogy Therapeutics, Inc. Methods of treating lung infection with caspofungin
HK1258533A1 (zh) 2016-01-08 2019-11-15 Cidara Therapeutics, Inc. 防止和治疗肺孢子虫感染的方法
JP7224916B2 (ja) 2016-03-16 2023-02-20 シダラ セラピューティクス インコーポレーテッド 真菌感染の処置のための投薬レジメン
WO2017185030A1 (en) * 2016-04-22 2017-10-26 Fresenius Kabi Usa, Llc Caspofungin formulation with low impurities
CA3069423C (en) 2017-07-12 2025-04-15 Napp Pharmaceutical Group Limited Formulations for the treatment of fungal infections
WO2019157453A1 (en) 2018-02-12 2019-08-15 Trilogy Therapeutics, Inc. Caspofungin compositions for inhalation
EP3620462A1 (en) 2018-09-04 2020-03-11 Xellia Pharmaceuticals ApS Process for the preparation of caspofungin

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE851310A (fr) * 1976-02-12 1977-08-10 Sandoz Sa Nouveaux derives de la tetrahydro-equinocandine b
DE2704030A1 (de) * 1976-02-12 1977-08-18 Sandoz Ag Neue organische verbindungen, ihre herstellung und verwendung
DE2742435A1 (de) * 1976-09-28 1978-04-06 Sandoz Ag Aminoalkylaether der peptide tetrahydro- sl 7810/f-ii, s 31794/f-1, aculeacin a und tetrahydroechinocandin b, ihre verwendung und herstellung
US4293489A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4320053A (en) * 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912D nucleus
US4293485A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
US4287120A (en) * 1979-12-13 1981-09-01 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
EP0030844A1 (en) * 1979-12-13 1981-06-24 Eli Lilly And Company Recovery process for A-30912 antibiotics
DE3030554A1 (de) * 1980-08-13 1982-03-25 Chemische Werke Hüls AG, 4370 Marl Einbrennlacke
US4931352A (en) * 1987-10-07 1990-06-05 Merck & Co., Inc. Antifungal fermentation product
US5166135A (en) * 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
DK173802B1 (da) * 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
US5202309A (en) * 1989-06-30 1993-04-13 Merck & Co., Inc. Antibiotic cyclopeptide fermentation product
US5194377A (en) * 1989-06-30 1993-03-16 Merck & Co., Inc. Antibiotic agent
NZ234225A (en) * 1989-06-30 1993-09-27 Merck & Co Inc Antibiotic from zalerion arboricola and its use as an antifungal agent and antipneumocystis agent
US5021341A (en) * 1990-03-12 1991-06-04 Merck & Co., Inc. Antibiotic agent produced by the cultivation of Zalerion microorganism in the presence of mannitol
GB8925593D0 (en) * 1989-11-13 1990-01-04 Fujisawa Pharmaceutical Co Fr901379 substance and preparation thereof
US5159059A (en) * 1990-05-29 1992-10-27 Merck & Co., Inc. Process for reduction of certain cyclohexapeptide compounds
US5219985A (en) * 1990-10-31 1993-06-15 Merck & Co., Inc. Antifungal agent
MY136593A (en) * 1992-03-19 2008-10-31 Lilly Co Eli Cyclic peptide antifungal agents and process for preparation thereof
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
US5516757A (en) * 1994-09-16 1996-05-14 Merck & Co., Inc. Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use
US5516756A (en) * 1994-10-31 1996-05-14 Merck & Co., Inc. Aza cyclohexapeptide compounds

Also Published As

Publication number Publication date
NO2005020I1 (no) 2005-09-13
AU668804B2 (en) 1996-05-16
AU5783294A (en) 1994-09-22
RO113246B1 (ro) 1998-05-29
FI954327L (fi) 1995-09-14
DE69421639D1 (de) 1999-12-23
NL300076I2 (nl) 2002-04-02
ZA941807B (en) 1994-10-13
SK113695A3 (en) 1996-02-07
DE10299013I1 (de) 2003-01-23
IL108892A (en) 1998-07-15
KR100329693B1 (ko) 2002-08-14
PL179261B1 (pl) 2000-08-31
IL108892A0 (en) 1994-06-24
DE10299013I2 (de) 2009-11-19
UA59329C2 (uk) 2003-09-15
US5378804A (en) 1995-01-03
BR9406009A (pt) 1995-12-26
RU2122548C1 (ru) 1998-11-27
CA2118757A1 (en) 1994-09-17
NO2005020I2 (no) 2008-12-01
JP2568474B2 (ja) 1997-01-08
CN1098274C (zh) 2003-01-08
HRP940161A2 (en) 1996-08-31
NO953648L (no) 1995-11-15
PL310634A1 (en) 1995-12-27
KR960701092A (ko) 1996-02-24
BR1100273A (pt) 1999-10-13
DK0620232T3 (da) 2000-03-13
LV12574A (en) 2000-11-20
HK1008674A1 (en) 1999-05-14
EP0620232B1 (en) 1999-11-17
NL300076I1 (nl) 2002-03-01
NO953648D0 (no) 1995-09-15
DE69421639T2 (de) 2000-06-08
BG99999A (bg) 1996-04-30
NO318372B1 (no) 2005-03-14
LV12574B (en) 2001-04-20
ATE186736T1 (de) 1999-12-15
HRP940161B1 (en) 2001-04-30
WO1994021677A1 (en) 1994-09-29
HU9502703D0 (en) 1995-11-28
HU217614B (hu) 2000-03-28
EP0620232A1 (en) 1994-10-19
SI9420013B (sl) 2002-12-31
CN1119441A (zh) 1996-03-27
HU211890A9 (en) 1995-12-28
FI954327A0 (fi) 1995-09-14
CZ235895A3 (en) 1996-02-14
FI109542B (fi) 2002-08-30
GR3031872T3 (en) 2000-02-29
SK282527B6 (sk) 2002-10-08
SI9420013A (en) 1996-08-31
CA2118757C (en) 2002-05-14
CZ286235B6 (cs) 2000-02-16
NZ263360A (en) 1997-08-22
BG63047B1 (bg) 2001-02-28
HUT73496A (en) 1996-08-28
LU90875I2 (en) 2002-03-04
JPH06321986A (ja) 1994-11-22
US5514650A (en) 1996-05-07
US5792746A (en) 1998-08-11

Similar Documents

Publication Publication Date Title
ES2139043T3 (es) Compuestos de azaciclohexapeptidos.
ZA9710796B (en) Oxyiminopregnanecarbolactones.
FI950075A7 (fi) Parannettuja kemiluminoivia 1,2-dioksetaaneja
AU3771597A (en) Novel benzamidines
BG101892A (en) Sugar-modified cytostatics
TR200003587T2 (tr) Nosatiasin antibiyotikleri.
GR920300076T1 (en) 1,2-dioxetane compounds as chemiluminescent labels for organic and biological molecules
DK0721453T3 (da) Fremgangsmåde til fremstilling af N-methyl-3-(1-methyl-4-piperidinyl)-14-indol-5-ethansulfonamid
YU22797A (sh) Postupak i intermedijarna jedinjenja za dobijanje pesticidnih fluoroolefinskih jedinjenja
AU3774097A (en) Intermediates for the preparation of 2-imidazoline-5-ones
BR9606955A (pt) Heterocicloalquenos substituísos
AR012449A1 (es) Kodaistatinas a, b, c y d, proceso para su produccion, y su uso.
AU640514C (en) 1,2-dioxetane compounds as chemiluminescent lables for organic and biological molecules
EE04369B1 (et) Alfa-arüülalkaanhapete valmistamismeetod
ITRM940091A0 (it) Procedimento per la preparazione di colture cellulari di eisenia foetida (anellidi, oligocheti).
AU652099C (en) Alkene intermediates for the production of certain 1,2-dioxetane compounds
IT8921757V0 (it) Guarnizione, per rivestire i bordi di corpi, destinati alla produzione di mobili.
ES1025952U (es) Elementos para mueble modular.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 620232

Country of ref document: ES

SPCF Request for supplementary protection certificate filed

Free format text: CASPOFUNGINA (CASPOFUNGIN MSD)

Spc suppl protection certif: C200200007

Filing date: 20020212

SPCG Supplementary protection certificate granted

Free format text: CASPOFUNGINA (CASPOFUNGIN MSD).

Spc suppl protection certif: C200200007

Filing date: 20020212

Expiry date: 20161024

Effective date: 20040614